Starlix som monoterapi viste sig at være mere effektiv end placebo, men mindre effektiv end visse lægemidler mod diabetes såsom metformin.
On its own, Starlix was shown to be more effective than placebo, but less effective than some antidiabetes medicines such as metformin.